Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 170-177

  Huang, Wei Lieh ^a,b   Chang, Li Ren ^a   Kuo, Terry B J ^b,c   Lin, Yu Hsuan ^a   Chen, Ying Zai ^a   Yang, Cheryl C H ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

anticholinergics; antipsychotics; heart rate variability; muscarinic affinity; schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BIPERIDEN; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; ESTAZOLAM; FLUNITRAZEPAM; FLUPENTIXOL; HALOPERIDOL; LORAZEPAM; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIHEXYPHENIDYL;

ADULT; AKATHISIA; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; FREQUENCY MODULATION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, MUSCARINIC; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 84874936793     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182839052     Document Type: Article

References (49)

1. Laviolette SR. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia Schizophr Bull. 2007;33:971-981. (Pubitemid 47216650)
2. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20:201-225. (Pubitemid 29067401)
3. Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev. 2000;31:302-312. (Pubitemid 30136185)
4. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ. 2005;172:1703-1711. (Pubitemid 40896865)
5. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93. (Pubitemid 40677047)
6. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns Curr Pharm Des. 2004;10:2463-2475. (Pubitemid 38997427)
7. Fayek M, Kingsbury SJ, Zada J, et al. Cardiac effects of antipsychotic medications. Psychiatr Serv. 2001;52:607-609. (Pubitemid 32429289)
8. Nielsen J, Andersen MP, Graff C, et al. The effect of sertindole on QTD and TPTE. Acta Psychiatr Scand. 2010;121:385-388.
9. Nielsen J, Graff C, Hardahl T, et al. Sertindole causes distinct electrocardiographic T-wave morphology changes. Eur Neuropsychopharmacol. 2009;19:702-707.
10. Nasrallah HA. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008;13:27-35. (Pubitemid 350275185)
11. National Institute of Mental Health Psychoactive Drug Screening Program (PDSP) Database. [Cited 6 November 2011.] Available from URL: http://pdsp.med.unc.edu (last accessed 15 February 2012).
12. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev. 1999;51:651-690.
13. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:1439-1450.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
15. Kuo TB, Lin T, Yang CC, et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol. 1999;277:H2233-H2239. (Pubitemid 30048142)
16. Wu GQ, Arzeno NM, Shen LL, et al. Chaotic signatures of heart rate variability and its power spectrum in health, aging and heart failure. PLoS One. 2009;4:e4323.
17. Huikuri HV, Seppanen T, Koistinen MJ, et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation. 1996;93:1836-1844. (Pubitemid 26154035)
18. Toichi M, Kubota Y, Murai T, et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol. 1999;31:147-154. (Pubitemid 29049406)
19. Bar KJ, Letzsch A, Jochum T, et al. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res. 2005;39:519-527. (Pubitemid 40909996)
20. Boettger S, Hoyer D, Falkenhahn K, et al. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin Neurophysiol. 2006;117:2715-2722. (Pubitemid 44751625)
21. Chang JS, Yoo CS, Yi SH, et al. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:924-929.
22. Rachow T, Berger S, Boettger MK, et al. Nonlinear relationship between electrodermal activity and heart rate variability in patients with acute schizophrenia. Psychophysiology. 2011;48:1323-1332.
23. Chang LR, Lin YH, Kuo TB, et al. Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management. PLoS One. 2011;6:e26378.
24. Bar KJ, Boettger MK, Berger S, et al. Decreased baroreflex sensitivity in acute schizophrenia. J Appl Physiol. 2007;102:1051-1056. (Pubitemid 46377031)
25. Bar KJ, Boettger MK, Schulz S, et al. The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol. 2008;119:2209-2213.
26. Rachow T, Berger S, Boettger MK, et al. Nonlinear relationship between electrodermal activity and heart rate variability in patients with acute schizophrenia. Psychophysiology. 2011;48:1323-1332.
27. Malaspina D, Dalack G, Leitman D, et al. Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr. 2002;7:53-57. (Pubitemid 34773519)
28. Hempel RJ, Tulen JH, van Beveren NJ, et al. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol. 2009;23:697-707.
29. AgelinkMW, Majewski T,Wurthmann C, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol. 2001;21:8-13.
30. Kim JH, Yi SH, Yoo CS, et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28: 371-378. (Pubitemid 38139268)
31. Mueck-Weymann M, Rechlin T, Ehrengut F, et al. Effects of olanzapine and clozapine upon pulse rate variability. Depress Anxiety. 2002;16:93-99. (Pubitemid 35334664)
32. Eschweiler GW, Bartels M, Langle G, et al. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine Pharmacopsychiatry. 2002;35: 96-100. (Pubitemid 34651915)
33. Penttila J, Kuusela T, Scheinin H. Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans. Eur J Clin Pharmacol. 2005;61:559-565. (Pubitemid 41414239)
34. Okada T, Toichi M, Sakihama M. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia. J Clin Psychopharmacol. 2003;23:441-447. (Pubitemid 37128670)
35. Golds PR, Przyslo FR, Strange PG. The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol. 1980;68:541-549. (Pubitemid 10150998)
36. Peuskens J. The management of schizophrenia: focus on extended-release quetiapine fumarate. Neuropsychiatr Dis Treat. 2011;7:549-564.
37. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663-667. (Pubitemid 36750143)
38. Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol. 1998;8:55-66.
39. Andreasen NC, Pressler M, Nopoulos P, et al. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67:255-262.
40. Cheng JJ, Ho H, Chang CJ, et al. Positive and Negative Syndrome Scale (PANSS): establishment and reliability study of a mandarin Chinese language version. Chinese Psychiatry. 1996;10:251-258.
41. Wang YC, Yang CC, Bai YM, et al. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008;57:200-205.
42. Toivonen L. Influence of acute alpha 1-adrenergic antagonism on heart rate variability in patients with old myocardial infarction. J Cardiovasc Pharmacol. 1994;23:932-935. (Pubitemid 24166657)
43. Dabrowska B, Pruszczyk P, Dabrowski A, et al. Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in phaeochromocytoma. J Hum Hypertens. 1995;9:925-929.
44. Freeman R, Weiss ST, Roberts M, et al. The relationship between heart rate variability and measures of body habitus. Clin Auton Res. 1995;5:261-266.
45. Guizar JM, Ahuatzin R, Amador N, et al. Heart autonomic function in overweight adolescents. Indian Pediatr. 2005;42:464-469. (Pubitemid 40732910)
46. Lampert R, Ickovics JR, Viscoli CJ, et al. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Am J Cardiol. 2003;91:137-142. (Pubitemid 36084296)
47. Tory K, Horvath E, Suveges Z, et al. Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol. 2004;61:316-323. (Pubitemid 38579017)
48. Agelink MW, Majewski TB, Andrich J, et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002;30:997-1006. (Pubitemid 34508020)
49. Unoki T, Grap MJ, Sessler CN, et al. Autonomic nervous system function and depth of sedation in adults receiving mechanical ventilation. Am J Crit Care. 2009;18:42-50.